Sort By:
Featured

Migraine Relief and Motility

The purpose of this study is to measure gastrointestinal transit time in adult patients with migraines before and after initiation of CGRP medication. This study will be open label and you will either be given Emgality or Aimovig. You will use a wireless motility capsule (WMC) technology that tracks and records the speed of your stomach emptying. This will be done before and after the medication is administered.

View Trial Details
Ages 18 - 55
Study Topics Migraine

Migraine Relief Intranasal Spray

Rochester Clinical Research is conducting a study to evaluate the efficacy of the investigational nasal powder for the treatment of an acute migraine. The purpose of the study is to evaluate a new delivery system for an established migraine medication called dihydroergotamine, or DHE. The study will be a single intranasal dose and aims to give migraine symptom relief within two hours of taking the medication .

View Trial Details
Ages 18 - 65
Compensation* $300
Study Topics Migraines

*Compensation for time and travel may be available to those who qualify.